S

Seer

IPO

The promise of proteomics NOW IN FULL VIEW

Redwood City, United States · Founded 2017 · $102.5M raised

Employees
51–200
Founded
2017
Business Model
B2B
Total Funding
$102.5M
Last Round
$17.5M Series CMar 2018
Rounds
4

About

Seer enables unbiased, deep, rapid proteomics at scale through the Proteograph Product Suite. The platform captures more protein groups and enhances peptide-level coverage, giving researchers higher-resolution views of biological complexity across human and nonhuman samples. Teams can bring the Proteograph Product Suite in-house, run a project with the Seer Technology Access Center, or work through a Seer service provider or Center of Excellence. Seer reports more than 36,000 proteins and over 300,000 peptides providing high-resolution information on the proteome.

Summary

Seer is a Biotech company based in Redwood City, United States, founded in 2017. It has raised $102.5M in total across 4 rounds, most recently a $17.5M Series C round in Mar 2018. Investors include Maverick Ventures, Invus and Fidelity Management.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

IPODec 2020
$175.0M

Sign up to see all 5 rounds

Series C through IPO — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Seer on Indexed.vc
<a href="https://indexed.vc/companies/seer"><img src="https://indexed.vc/api/badge/company/seer" alt="Seer on Indexed.vc" width="260" height="76" /></a>